Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination

Psychopharmacology Bulletin

Volumn 44, Issue 1, 2011, Pages 70-73

  Pratheesh, P J ^a   Praharaj, Samir Kumar ^a   Srivastava, Ashish ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b Institute of Psychiatry and Human Behavior   (India)

Author keywords

Fluvoxamine; Galactorrhea; Gynecomastia; Risperidone

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; FLUVOXAMINE; PAROXETINE; PROLACTIN; RISPERIDONE;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GALACTORRHEA; GYNECOMASTIA; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PHYSICAL EXAMINATION; PROLACTIN BLOOD LEVEL; SEDATION; SIDE EFFECT;

DRUG THERAPY, COMBINATION; FLUVOXAMINE; GALACTORRHEA; GYNECOMASTIA; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROLACTIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 82155178476     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs. 2004;64:2291-2314.
2. Findling RL, Kusumakar V, Daneman D, et al. Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry. 2003;64:1362-1369.
3. Kleinberg DL, Davis JM, De Coster R, et al. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol. 1999;19:57-61.
4. Holzer L, Eap CB. Risperidone-induced symptomatic hyperprolactinaemia in adolescents. J Clin Psychopharmacol. 2006;26:167-171.
5. Hall MJ. Breast tenderness and enlargement induced by sertraline. Am J Psychiatry. 1994;151: 1395-1396.
6. Peterson MC. Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc. 2001;76:215-216.
7. Gulsun M, Evrensel A, Verim S. Galactorrhea during escitalopram treatment: a case report. Bull Clin Psychopharmacol. 2006;16:39-41.
8. Shim SH, Lee YJ, Lee EC. A case of galactorrhea associated with excitalopram. Psychiatry Investig. 2009;6:230-232.
9. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol. 1997;17:292-297.
10. D'Arrigo C, Migliardi G, Santoro V, et al. Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. Pharmacol Res. 2005;52:497-501.
11. Erzegovesi S, Guglielmo E, Siliprandi F, et al. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol. 2005;15:69-74.
12. Gulsun M, Algul A, Semiz UB, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med. 2007;37:275-278.
13. Chen CK, Huang YS, Ree SC, et al. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1495-1499.